GIA® vs Neurotrack — Speech Biomarkers vs Digital Cognitive Battery
GIA® by Scienza Health analyzes 2,500+ speech biomarkers during a 40-second natural conversation by phone, video, or landline, screening for 46 conditions across cognitive, neurological, and behavioral health. Neurotrack delivers a 3-minute digital cognitive battery on a tablet, smartphone, or desktop — focused on cognitive impairment detection only. A clinician reviews every result from either tool — clinical standard for any screening instrument. Neither tool diagnoses.
Side-by-Side Comparison
| Feature | GIA® by Scienza Health | Neurotrack |
|---|---|---|
| Screening method | Speech biomarkers — natural conversation | Digital cognitive battery — structured tasks |
| Time to complete | 40 seconds | 3 minutes |
| Device required | Any phone, video, or landline | Tablet, smartphone, or desktop |
| Where completed | Before appointment — any location | In clinic or remotely |
| Staff required | Zero — no staff needed | MA sets up or self-administered |
| Conditions screened | 46 cognitive, neurological, and behavioral | Cognitive impairment — MCI and dementia |
| Behavioral health | Depression AUC 0.816, Anxiety AUC 0.775, PTSD AUC 0.800 | Not available |
| ADL/IADL assessment | Yes — Barthel, Katz, Lawton, FIM | Not available |
| BIMS administration | Yes — MDS 3.0 Section C | Not available |
| Post-acute/SNF setting | Primary market | Limited focus |
| Languages | 92 | Culturally agnostic symbols |
| Peer-reviewed validation | 19 studies — independent researchers | 25 peer-reviewed studies |
| EHR integration | PointClickCare, Epic, Cerner, MatrixCare | All EHRs |
| FDA status | FDA-registered establishment | FDA-registered |
| Founded | 2024 | 2012 |
| Dataset | 12.3M+ patients, 27B+ clinical records | Not publicly specified |
| Proactive Decision Orders (PDO) | Yes — nightly EHR population analysis, ranked clinical recommendations before rounds | Not available |
| Population-level intelligence | PDO analyzes full EHR population every night — surfaces which patients need attention today | Screening tool only — no population analysis layer |
The Core Difference — Natural Speech vs Structured Tasks
Neurotrack’s cognitive battery asks patients to complete structured digital tasks — memory exercises, symbol matching, and attention tests — on a screen. The platform scores results instantly and delivers them to the EHR. It is self-administered and can be completed remotely, which reduces the in-clinic burden significantly.
GIA® by Scienza Health does not ask patients to perform structured tasks. It analyzes naturally occurring speech patterns from a 40-second natural conversation completed before the appointment on any phone, video connection, or landline. The patient does not need to interact with a device, navigate an app, or complete exercises. Results are in the EHR before the clinician enters the room.
The practical implication: GIA® works for patients who are uncomfortable with digital devices, live in areas with limited internet, or cannot attend in-person visits. The landline option is particularly relevant for SNF and homebound populations that Neurotrack’s device-based approach does not serve as effectively.
What Each Tool Is Best For
GIA® by Scienza Health
- Screening before the appointment with zero added clinical time
- Post-acute, SNF, and PACE settings
- Multi-condition screening covering behavioral health, cognitive, and neurological risk
- Homebound and landline patients
- ADL and IADL assessment alongside cognitive screening
- BIMS and MDS 3.0 compliance
- 92-language diverse populations
- Population-level proactive clinical intelligence via PDO — nightly EHR analysis surfaces ranked recommendations before rounds across the entire facility
- Built on 19 peer-reviewed studies across a dataset of 12.3M+ patients and 27B+ clinical records
Neurotrack
- Self-administered digital cognitive screening in clinic or remotely
- Primary care AWV workflow
- Health system cognitive screening programs
- Patients comfortable with digital devices
- Organizations targeting cognitive impairment and dementia detection specifically
This comparison is based on publicly available information from Neurotrack’s website and published research as of April 2026. Tool capabilities may change — verify current features directly with each vendor.
Beyond Screening — The PDO Difference
GIA® by Scienza Health is one component of a broader clinical intelligence platform. PDO — Proactive Decision Orders — analyzes the full EHR population every night and surfaces ranked clinical recommendations before rounds. PDO identifies which patients across the facility need attention today, surfaces early risk signals, and delivers physician-approved order sets for clinician review. No competing cognitive screening tool includes a population-level intelligence layer.
Linus Health and Neurotrack are cognitive screening tools. GIA® by Scienza Health includes both patient-level screening and facility-level population intelligence.
Frequently Asked Questions
How does GIA® differ from Neurotrack?
GIA® by Scienza Health analyzes speech biomarkers from a 40-second natural conversation on any phone or landline — no device or app required. Neurotrack delivers a 3-minute structured digital cognitive battery on a tablet, smartphone, or computer. GIA® screens for 46 conditions including behavioral health. Neurotrack focuses on cognitive impairment and dementia detection. Both require clinician review and neither diagnoses.
Can GIA® work for patients without digital devices?
Yes. GIA® by Scienza Health deploys via standard phone call or landline — no smartphone, tablet, or internet connection required. This makes GIA® suitable for SNF residents, homebound patients, and populations in areas with limited digital access. Neurotrack requires a tablet, smartphone, or desktop computer.
Does GIA® screen for conditions beyond cognitive impairment?
Yes. GIA® screens for 46 conditions including cognitive decline (AUC 0.890), depression (AUC 0.816), anxiety (AUC 0.775), PTSD (AUC 0.800), Parkinson's disease (AUC 0.97), and 40+ additional neurological and behavioral conditions. Neurotrack focuses on cognitive impairment and MCI/dementia detection. For clinicians who need simultaneous cognitive and behavioral health screening, GIA® covers both.
Which tool has more peer-reviewed validation?
Neurotrack has published 25 peer-reviewed studies. GIA® by Scienza Health has been validated across 19 peer-reviewed studies by independent researchers at Beth Israel Deaconess Medical Center, NIH, and MIT. Both tools have published validation data. Clinical suitability depends on the care setting, patient population, and clinical purpose.